Verona Pharma (VRNA)
NASDAQ: VRNA
· Real-Time Price · USD
105.26
-0.01 (-0.01%)
At close: Aug 15, 2025, 3:59 PM
105.27
0.01%
After-hours: Aug 15, 2025, 04:15 PM EDT
Verona Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 401.42M | 399.76M | 336.04M | 404.6M | 254.88M | 271.77M | 257.37M | 270.73M | 291.42M | 227.83M | 231.7M | 111.51M | 132.76M | 148.38M | 166.55M | 146.03M | 169.6M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | n/a | n/a |
Other Long-Term Assets | 22.56M | 1.97M | n/a | 15M | 15.02M | n/a | 15.01M | 15.01M | 15.01M | 15.07M | 15.08M | 15.09M | 15.07M | 15.08M | 15.09M | n/a | n/a |
Receivables | 62.16M | 37.26M | 16.81M | 3.68M | 11.46M | 10.95M | 9.51M | 10.15M | 11.84M | 9.28M | 20.32M | 20.18M | 16.42M | 15.58M | 10.61M | 2.89M | n/a |
Inventory | 7.24M | 6.25M | 4.32M | n/a | n/a | n/a | 3.33M | 894K | 1.56M | 2.5M | 3.35M | 4.73M | 1.25M | 4.04M | 6.67M | 9.82M | 6.87M |
Other Current Assets | 30.21M | 2.73M | 3.44M | 2.58M | 1.88M | 3.37M | 6.32M | 6.06M | 2.07M | 3.39M | 3.08M | 2.21M | 2.52M | 2.06M | 667K | 2.32M | 8.53M |
Total Current Assets | 501.02M | 453.57M | 364.25M | 416.29M | 271.84M | 289.71M | 276.53M | 287.83M | 306.89M | 243M | 258.45M | 138.63M | 152.96M | 170.06M | 184.49M | 216.28M | 188.6M |
Property-Plant & Equipment | 1.81M | 3.15M | 2.02M | 2.29M | 2.53M | 2.87M | 398K | 553K | 710K | 927K | 874K | 679K | 815K | 979K | 1.52M | 1.67M | 1M |
Goodwill & Intangibles | 545K | 545K | 545K | 545K | 545K | 545K | 545K | 545K | 545K | 545K | 544K | 545K | 545K | 545K | 545K | 545K | 545K |
Total Long-Term Assets | 24.91M | 20.67M | 17.57M | 17.83M | 18.07M | 18.42M | 15.94M | 16.1M | 16.25M | 16.47M | 16.42M | 16.22M | 16.36M | 16.52M | 17.07M | 2.22M | 1.55M |
Total Assets | 525.94M | 474.24M | 381.82M | 434.12M | 289.91M | 308.12M | 292.47M | 303.93M | 323.15M | 259.47M | 274.87M | 154.86M | 169.31M | 186.59M | 201.56M | 218.5M | 190.15M |
Account Payables | 9.08M | 11.27M | 6.83M | 4.15M | 4.65M | 3.49M | 823K | 2.49M | 7.24M | 2.91M | 8M | 9.36M | 8.06M | 10.04M | 9K | 34K | 541K |
Deferred Revenue | n/a | 687K | n/a | 1.01M | n/a | n/a | 7.4M | 7.47M | n/a | n/a | n/a | 9.36M | n/a | 22.4M | 26.85M | 40.05M | 8.51M |
Short-Term Debt | 1.08M | 1.12M | 952K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 690K | 749K | 757K |
Other Current Liabilities | 46.39M | 1.74M | 19.21M | 22.52M | 736K | 435K | 416K | 444K | 509K | 1.41M | 294K | 121K | 144K | 327K | -503K | -407K | 2.13M |
Total Current Liabilities | 56.54M | 42.68M | 27.95M | 48.35M | 14.77M | 8.69M | 9.01M | 10.95M | 26.52M | 19.03M | 32.13M | 38.86M | 37.9M | 33.42M | 27.74M | 58.36M | 12.7M |
Long-Term Debt | 1.05M | 120.34M | 120.01M | 119.69M | 38.47M | 48.37M | 19.91M | 15.64M | 19.81M | 9.77M | 5.04M | 4.98M | 4.93M | 4.87M | 4.82M | 4.77M | 4.68M |
Other Long-Term Liabilities | 241.74M | n/a | 102.02M | 96.34M | 10.07M | n/a | n/a | 4.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 242.8M | 227M | 223.38M | 217.5M | 50.15M | 50.15M | 19.93M | 19.89M | 19.87M | 9.97M | 5.26M | 5.11M | 5.11M | 5.16M | 5.62M | 5.74M | 5.04M |
Total Liabilities | 299.34M | 269.68M | 251.33M | 265.85M | 64.92M | 58.84M | 28.94M | 30.84M | 46.4M | 29M | 37.39M | 43.98M | 43.01M | 38.58M | 33.36M | 64.11M | 17.74M |
Total Debt | 2.13M | 122.7M | 122.31M | 218.53M | 51.27M | 51.33M | 20.3M | 20.43M | 20.52M | 10.65M | 5.83M | 5.58M | 5.69M | 5.81M | 6.31M | 6.49M | 5.79M |
Common Stock | 43.62M | 45.02M | 42.77M | 42.77M | 42.77M | 42.77M | 41.75M | 41.75M | 41.75M | 40.53M | 39.12M | 32.18M | 32.18M | 31.86M | 31.86M | 31.82M | 31.79M |
Retained Earnings | -578.79M | -562.4M | -528.48M | -485.31M | -414.4M | -388.43M | -374.05M | -359.14M | -350.11M | -333.1M | -322.44M | -306.65M | -288.74M | -263.72M | -240.29M | -251.26M | -228.37M |
Comprehensive Income | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M | -4.6M |
Shareholders Equity | 226.59M | 204.56M | 130.49M | 168.27M | 224.99M | 249.28M | 263.53M | 273.09M | 276.75M | 230.47M | 237.49M | 110.88M | 126.31M | 148M | 168.2M | 154.4M | 172.41M |
Total Investments | n/a | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | 15M | n/a | n/a |